Krka's nine-month R&D spending up by 47%
This article was originally published in Scrip
Executive Summary
Krka's spending on R&D increased by 47% to €61.8 million in the first nine months of this year. The company received first market authorisations for 11 new products in 25 formulations and acquired 374 marketing authorisations in different countries.